Compare PRPL & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPL | OM |
|---|---|---|
| Founded | 2010 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.9M | 73.4M |
| IPO Year | 2015 | 2020 |
| Metric | PRPL | OM |
|---|---|---|
| Price | $0.64 | $4.37 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $0.85 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 283.1K | 106.9K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 152.75 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $468,725,000.00 | $119,476,000.00 |
| Revenue This Year | $10.83 | $9.16 |
| Revenue Next Year | $6.81 | $11.19 |
| P/E Ratio | $1.25 | ★ N/A |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $0.57 | $3.00 |
| 52 Week High | $1.26 | $21.98 |
| Indicator | PRPL | OM |
|---|---|---|
| Relative Strength Index (RSI) | 45.72 | 68.86 |
| Support Level | $0.57 | $4.00 |
| Resistance Level | $0.73 | $4.97 |
| Average True Range (ATR) | 0.04 | 0.21 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 24.24 | 95.54 |
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.